Erratum

This article refers to:

Safety considerations when prescribing immunosuppression medication to pregnant women

Correction to: Safety considerations when prescribing immunosuppression medication to pregnant women

Gerosa M, Meroni PL, Cimaz R. Safety considerations when prescribing immunosuppression medication to pregnant women. Expert Opin Drug Saf 2014 Dec;13(12):1591-9.

Following publication of this article, PL Meroni noted that his second affiliation had not been listed on the paper. The inclusion of this affiliation is important and required by his second institution.

The affiliation list should appear as follows

Maria Gerosa^†1 MD, Pier Luigi Meroni^1,3 & Rolando Cimaz²

^†Author for correspondence

¹University of Milan, Ospedale Gaetano Pini, Division of Rheumatology, Department of Clinical Sciences and Community Health, via Pini 9, 20122 Milan, Italy. Tel: [phone]; Fax: [phone]; E-mail: [email protected]

²Anna Meyer Children’s Hospital and University of Florence, via Pieraccini 24, 50141, Florence, Italy

³IRCCS Istituto Auxologico Italiano, Milan, Italy